Silexion Therapeutics Corp
SLXN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002022416
No open-market purchases or sales by Silexion Therapeutics Corp insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $42.5K in total; no superinvestor holds it.
Other share classesSLXNW
Holders of 5% or more of SLXN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Silexion Therapeutics Corp, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Moringa Sponsor, LP | 13D/A | 25.00%1.39M shares | +14.40 ppfrom 10.60% | Sep 23, 20254 filings | Aug 19, 2026 | SEC |
| Lincoln Alternative Strategies LLC | 13G | 6.18%131.3K shares | New | Sep 15, 20251 filing | Sep 15, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
19 Schedule 13D and 13G filings on Silexion Therapeutics Corp, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 19, 20268:19 PM ET | Moringa Sponsor, LPand 2 others | 13D/A | 25.00%1.39M shares | +14.40 ppfrom 10.60% | Jul 30, 2026 | SEC |
| Aug 18, 20265:36 PM ET | Intracoastal Capital, LLCand 2 others | 13G | 4.99%286.9K shares | −4.41 ppfrom 9.40%Below 5% | Aug 11, 2026 | SEC |
| Jun 23, 20264:00 PM ET | Moringa Sponsor, LPand 2 others | 13D/A | 10.60%199.1K shares | −22.39 ppfrom 32.99% | Jun 14, 2026 | SEC |
| May 29, 20264:00 PM ET | Moringa Sponsor, LPand 2 others | 13D/A | 32.99%1.38M shares | +18.32 ppfrom 14.67% | May 14, 2026 | SEC |
| May 15, 20264:13 PM ET | Lind Global Fund III LPand 2 others | 13G/A | 4.96%212.5K shares | −1.44 ppfrom 6.40%Below 5% | Mar 31, 2026 | SEC |
| Feb 13, 20264:49 PM ET | Intracoastal Capital, LLCand 2 others | 13G/A | 9.40%325.0K shares | −0.59 ppfrom 9.99% | Dec 31, 2025 | SEC |
| Nov 14, 20254:09 PM ET | Lind Global Fund III LPand 2 others | 13G/A | 6.40%212.5K shares | −3.50 ppfrom 9.90% | Sep 30, 2025 | SEC |
| Sep 23, 202511:17 AM ET | Moringa Sponsor, LPand 2 others | 13D/A | 14.67%458.8K shares | – | Sep 15, 2025 | SEC |
| Sep 18, 20255:47 PM ET | Lind Global Fund III LPand 2 others | 13G | 9.90%224.1K shares | New | Sep 12, 2025 | SEC |
| Sep 17, 20255:14 PM ET | Intracoastal Capital, LLCand 2 others | 13G | 9.99%244.8K shares | New | Sep 11, 2025 | SEC |
| Sep 15, 20255:23 PM ET | Orca Capital AG | 13G/A | 4.90%109.4K shares | −1.30 ppfrom 6.20%Below 5% | Sep 11, 2025 | SEC |
| Sep 15, 20255:19 PM ET | Orca Capital AG | 13G | 6.20%131.3K shares | New | Sep 11, 2025 | SEC |
| Sep 15, 202512:31 PM ET | Lincoln Alternative Strategies LLC | 13G | 6.18%131.3K shares | New | Sep 12, 2025 | SEC |
| Jun 26, 20254:15 PM ET | Wildcat Capital Management, LLCand 2 others | 13D/A | 1.30%113.4K shares | –Below 5% | Jun 26, 2025 | SEC |
| May 13, 202511:36 AM ET | Goldman Sachs Group Incand 1 other | 13G/A | 2.40%211.9K shares | −4.20 ppfrom 6.60%Below 5% | Mar 31, 2025 | SEC |
| May 12, 202512:12 PM ET | CVI Investments, Inc.and 1 other | 13G/A | 4.90%456.5K shares | −3.60 ppfrom 8.50%Below 5% | Mar 31, 2025 | SEC |
| Feb 10, 20255:31 PM ET | Goldman Sachs Group Incand 1 other | 13G | 6.60%112.2K shares | New | Dec 31, 2024 | SEC |
| Jan 23, 202512:19 PM ET | CVI Investments, Inc.and 1 other | 13G | 8.50%339.0K shares | New | Jan 15, 2025 | SEC |
| Jan 21, 20255:49 PM ET | Intracoastal Capital, LLCand 2 others | 13G | 4.99%209.8K shares | NewBelow 5% | Jan 15, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Silexion Therapeutics Corp shares.
No Form 144 notices for Silexion Therapeutics Corp are on file.